Summary:
- This article discusses the potential use of gene editing technology, specifically CRISPR-Cas9, to treat a rare genetic disorder called Duchenne muscular dystrophy (DMD).
- DMD is a progressive and debilitating disease that primarily affects young boys, causing muscle degeneration and loss of mobility over time.
- The researchers explored the possibility of using CRISPR-Cas9 to correct the genetic mutation responsible for DMD, potentially providing a new treatment option for patients with this devastating condition.